Casper R. M. Gøtzsche is a Global Medical Director in Cell & Gene Therapy at Bayer, where they focus on neurology and cardiovascular initiatives. They co-founded RetiPharma IVS, developing innovative therapies for eye diseases, and held leadership roles at various esteemed institutions, including UCB and CombiGene. Casper completed a PhD in Health and Medical Sciences at the University of Copenhagen and has contributed as a guest researcher at Lund University and Hannover Medical School. Additionally, they have pursued advanced leadership training and have a strong foundation in biomedical research from their academic background.
This person is not in the org chart
This person is not in any teams
This person is not in any offices